Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7560523 | 1.00 | UGT2B7 (0.47) | UGT2B7CYP1A2ALDH1A1HSD17B10HPGD | |
| Trifluoroethanol SCHEMBL2293008 | 0.86 | UGT2B7 (0.37) | UGT2B7CYP1A2ALDH1A1HSD17B10HPGD | |
| SCHEMBL8671624 | 0.83 | RECQL (0.41) | UGT2B7CYP1A2ALDH1A1HSD17B10HPGD | |
| SCHEMBL40806 | 0.81 | ALDH1A1 (0.44) | UGT2B7CYP1A2ALDH1A1HSD17B10HPGD | |
| SCHEMBL488964 | 0.81 | ALDH1A1 (0.46) | CYP1A2ALDH1A1HSD17B10HPGDMEN1 | |
| SCHEMBL27500071 | 0.80 | CYP1A2 (0.40) | UGT2B7CYP1A2ALDH1A1HSD17B10HPGD | |
| SCHEMBL29853842 | 0.79 | ALDH1A1 (0.42) | CYP1A2ALDH1A1HSD17B10HPGDMEN1 | |
| SCHEMBL4642610 | 0.79 | ALDH1A1 (0.42) | CYP1A2ALDH1A1HSD17B10HPGDMEN1 | |
| SCHEMBL4876087 | 0.78 | ALDH1A1 (0.41) | CYP1A2ALDH1A1HSD17B10HPGDMEN1 | |
| SCHEMBL17841054 | 0.78 | ALDH1A1 (0.44) | UGT2B7CYP1A2ALDH1A1HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113316746-B | Hologram recording composition, hologram recording medium, hologram, and optical device and optical member using the hologram | 索尼集团公司 | 2024-01-09 | — | — | CN | claimed |
| CN-110407984-A | A kind of viscosity reduction fluorescent type poly carboxylic acid series water reducer and preparation method thereof | JIANGSU ARIT NEW MAT CO LTD | 2019-11-05 | — | — | CN | claimed |
| CN-105463439-B | The titanium metal material and its preparation method and application of rhodium complex modification | 广西中医药大学 | 2018-09-04 | — | — | CN | claimed |
| CN-105396174-B | A kind of method for preparing the titania nanotube with antibacterial anti-cancer properties | 广西中医药大学 | 2018-06-29 | — | — | CN | claimed |
| CN-105288727-B | The method that the titania nanotube with antibacterial anticancer is prepared using rhodium complex | 广西中医药大学 | 2018-06-29 | — | — | CN | claimed |
| CN-105396173-B | The method that the stainless steel with antibacterial anti-cancer properties is prepared using rhodium complex | 广西中医药大学 | 2018-06-29 | — | — | CN | claimed |
| CN-105327391-B | The method that the titania nanotube with antibacterial anticancer is prepared using complex of iridium | 广西中医药大学 | 2018-06-22 | — | — | CN | claimed |
| CN-105457088-B | A kind of method for preparing the titanium with antibacterial anti-cancer properties | 广西中医药大学 | 2018-04-03 | — | — | CN | claimed |
| CN-105463439-A | Rhodium-complex-modified titanium material and preparing method and application of rhodium-complex-modified titanium material | UNIV GUANGXI CHINESE MEDICINE | 2016-04-06 | — | — | CN | claimed |
| CN-105457088-A | Method for preparing titanium metal with antimicrobial and anticancer performance | UNIV GUANGXI CHINESE MEDICINE | 2016-04-06 | — | — | CN | claimed |
| EP-1478681-A1 | SPIN-ON-GLASS ANTI-REFLECTIVE COATINGS FOR PHOTOLITHOGRAPHY | Honeywell International, Inc. (US) | 2004-11-24 | — | — | EP | claimed |
| EP-1358295-A1 | TRIBOLUMINESCENT MATERIALS IN ADHESIVE COMPOSITIONS FOR USE IN ADHESIVE TAPE | Qinetiq Limited (GB) | 2003-11-05 | — | — | EP | claimed |
| US-20030144499-A1 | Photocleavable protecting groups and methods for their use | AFFYMETRIX, INC. (US) | 2003-07-31 | — | — | US | claimed |
| WO-2003044077-A1 | SPIN-ON-GLASS ANTI-REFLECTIVE COATINGS FOR PHOTOLITHOGRAPHY | HONEYWELL INTERNATIONAL INC. (US) | 2003-05-30 | — | — | WO | claimed |
| WO-2002062914-A9 | TRIBOLUMINESCENT MATERIALS IN ADHESIVE COMPOSITIONS FOR USE IN ADHESIVE TAPE | QINETIQ LTD (GB) | 2003-05-15 | — | — | WO | claimed |
| WO-2002062915-A1 | PAPER PRODUCTS CONTAINING TRIBOLUMINESCENT MATERIALS | QINETIQ LIMITED (GB) | 2002-08-15 | — | — | WO | claimed |
| WO-2002062914-A1 | TRIBOLUMINESCENT MATERIALS IN ADHESIVE COMPOSITIONS FOR USE IN ADHESIVE TAPE | QINETIQ LIMITED (GB) | 2002-08-15 | — | — | WO | claimed |
| US-6147205-A | ARYLALKYLOXYCARBONYL GROUPS; FOR SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND POLYPEPTIDES | AFFYMETRIX, INC. (US) | 2000-11-14 | — | — | US | claimed |
| WO-1998039348-A9 | PHOTOCLEAVABLE PROTECTING GROUPS AND METHODS FOR THEIR USE | — | 1999-02-18 | — | — | WO | claimed |
| WO-1998039348-A1 | PHOTOCLEAVABLE PROTECTING GROUPS AND METHODS FOR THEIR USE | AFFYMETRIX, INC. (US) | 1998-09-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144499-A1 | Photocleavable protecting groups and methods for their use | RTCB, RRS1, GAR1 | UGT2B7 3982/4885CYP1A2 4112/4885ALDH1A1 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.